Kiran Muzumdar Shaw, MD, Syngene International LTD gestures during the press conference to announce Initial Public offer in Mumbai on Thursday, 16 July 2015. Pharmaceutical company Biocon Ltd has fixed a price band for an initial public offering (IPO) of its subsidiary Syngene International Ltd at Rs.240-250 per equity share.
Tags: Director at Syngene International Limitedhorizontal
Credit balance: 0